Infosys names a new CEO: welcome to the hot-seat Salil S. Parekh

Former CapGemini man steps in after last CEO bailed after nasty sniping


Infosys has named its next leader: Salil S. Parekh will become as CEO an managing director as of January 2nd, 2018, and has been appointed for five years.

Parekh has spent the last 25 years of his working life at Capemini, where he reached the rank of deputy CEO and sat on the Group Executive Board.

Infosys needed a new CEO because its last one, Vishal Sikka, resigned after a whispering campaign that saw rumours of impropriety and anonymous criticism reach the Indian press. That campaign was believed to have tacit approval from Infosys founders who remained on the company's board.

Whatever the source, Sikka said his job had become untenable and quit in August 2017.

Infosys' chair Nandan Nilekani's canned statement said: “The Board believes that [Parekh] is the right person to lead Infosys at this transformative time in our industry.”

Technology Business Research senior services analyst Boz Hristov said: “To succeed … first and foremost Parekh must be really good on playing the company politics, because as we recently saw [Infosys co-founder] NRN Murthy is still the 'real' CEO behind the scenes. If Parekh gets under Murthy’s skin he has a chance to become the golden child”.

Hristov expects Parekh “initially to play the role of a mediator between old and new Infosys and then to become an innovator and disruptor”. But to succeed, he said, the new CEO will need to pull off divestments, reform Infosys' sales strategy and invest in “technology-inclined strategy consultancy of the caliber of Roland Berger”. If Parekh can't get those jobs done, Hristov said the new CEO will probably be out the door after about three years. ®

Similar topics


Other stories you might like

  • Google sours on legacy G Suite freeloaders, demands fee or flee

    Free incarnation of online app package, which became Workplace, is going away

    Google has served eviction notices to its legacy G Suite squatters: the free service will no longer be available in four months and existing users can either pay for a Google Workspace subscription or export their data and take their not particularly valuable businesses elsewhere.

    "If you have the G Suite legacy free edition, you need to upgrade to a paid Google Workspace subscription to keep your services," the company said in a recently revised support document. "The G Suite legacy free edition will no longer be available starting May 1, 2022."

    Continue reading
  • SpaceX Starlink sat streaks now present in nearly a fifth of all astronomical images snapped by Caltech telescope

    Annoying, maybe – but totally ruining this science, maybe not

    SpaceX’s Starlink satellites appear in about a fifth of all images snapped by the Zwicky Transient Facility (ZTF), a camera attached to the Samuel Oschin Telescope in California, which is used by astronomers to study supernovae, gamma ray bursts, asteroids, and suchlike.

    A study led by Przemek Mróz, a former postdoctoral scholar at the California Institute of Technology (Caltech) and now a researcher at the University of Warsaw in Poland, analysed the current and future effects of Starlink satellites on the ZTF. The telescope and camera are housed at the Palomar Observatory, which is operated by Caltech.

    The team of astronomers found 5,301 streaks leftover from the moving satellites in images taken by the instrument between November 2019 and September 2021, according to their paper on the subject, published in the Astrophysical Journal Letters this week.

    Continue reading
  • AI tool finds hundreds of genes related to human motor neuron disease

    Breakthrough could lead to development of drugs to target illness

    A machine-learning algorithm has helped scientists find 690 human genes associated with a higher risk of developing motor neuron disease, according to research published in Cell this week.

    Neuronal cells in the central nervous system and brain break down and die in people with motor neuron disease, like amyotrophic lateral sclerosis (ALS) more commonly known as Lou Gehrig's disease, named after the baseball player who developed it. They lose control over their bodies, and as the disease progresses patients become completely paralyzed. There is currently no verified cure for ALS.

    Motor neuron disease typically affects people in old age and its causes are unknown. Johnathan Cooper-Knock, a clinical lecturer at the University of Sheffield in England and leader of Project MinE, an ambitious effort to perform whole genome sequencing of ALS, believes that understanding how genes affect cellular function could help scientists develop new drugs to treat the disease.

    Continue reading

Biting the hand that feeds IT © 1998–2022